Pacritinib
Pacritinib (SB1518) is a potent inhibitor of both wild-type JAK2 (IC50=23 nM) and JAK2V617F mutant (IC50=19 nM) . Pacritinib also inhibits FLT3 (IC50=22 nM) and its mutant FLT3D835Y (IC50=6 nM) .
Product Specifications
CAS Number
937272-79-2
Product Name Alternative
SB1518
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
FLT3; JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pacritinib.html
Purity
99.93
Solubility
0.1 M HCl : 2 mg/mL (ultrasonic) |1 M HCl : ≥ 100 mg/mL|DMSO : 10 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
C1(COC/C=C/COCC2=C(OCCN3CCCC3)C=CC4=C2)=CC=CC(C5=N/C(NC=C5)=N\4)=C1
Molecular Formula
C28H32N4O3
Molecular Weight
472.58
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
JAK1; JAK2; JAK3; Tyk2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD3e (T-Cell Marker) (rC3e/1308), CF640R conjugate, 0.1mg/mL
IL3RA / CD123 (Acute Myeloid Leukemia Marker) (IL3RA/2065), CF594 conjugate, 0.1mg/mL
Recombinant Mouse Fibroblast Growth Factor 4/FGF-4